Following the launch of its Giving Back campaign earlier this year, a testing laboratory has announced its first round of donations to four UK charities that support some of the country’s most vulnerable children and families.
One of the charities that will benefit from the regular donations is the Birkenhead based National Youth Advocacy Service (NYAS), a charity that supports care-experienced young people.
In the first three months of the campaign, the DNA, Drug, Alcohol, and COVID-19 testing company has raised over £9,000 for its chosen charities.
For every legal testing instruction received from local authorities and family law organisations, AlphaBiolabs is donating £5 to four very worthy causes.
The other charities that will each receive an equal share of the donations are the National Association for Children of Alcoholics (Nacoa), Scottish Families Affected by Alcohol and Drugs (SFAD) and TGP Cymru.
Rachel Davenport, Director at AlphaBiolabs, said, “We carry out a wide range of drug and alcohol testing for local authorities and organisations involved in family law and child welfare, and our work therefore brings us into contact with some of the country’s most vulnerable children and families. We were concerned to learn how some charities working with these communities were struggling, especially with the increased demand for their services during the pandemic.”
She added, “We hope that our quarterly donations will help TGP Cymru, NYAS, Nacoa, SFAD and TGP Cymru continue to provide their vital services to those people who depend on them.”
Paula Hanford, Head of Income Generation at NYAS said, “We are incredibly grateful to AlphaBiolabs for choosing NYAS as one of their charity partners. The recent generous donation will help us to transform the future life chances for care leavers by providing them with much-needed support to enable them to achieve their goals.”
Throughout 2021, AlphaBiolabs will continue to donate £5 to charity for every legal instruction received from family law firms and local authorities.
Image: Rachel Davenport, AlphaBiolabs Director